Broadway Wealth Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$470K Sell
406
-25
-6% -$29.5K 0.21% 39
2026
Q2
$517K Buy
431
+19
+5% +$19.4K 0.24% 34
2026
Q1
$379K Buy
412
+4
+1% +$4.06K 0.2% 44
2025
Q4
$438K Sell
408
-67
-14% -$64.1K 0.23% 37
2025
Q3
$362K Buy
475
+29
+7% +$21.6K 0.2% 46
2025
Q2
$348K Buy
446
+29
+7% +$22.5K 0.22% 42
2025
Q1
$344K Sell
417
-54
-11% -$44.9K 0.25% 37
2024
Q4
$363K Buy
+471
New +$390K 0.28% 40

Other funds holding LLY

Broadway Wealth Solutions's LLY Position: Q3 2026 in Review

Broadway Wealth Solutions reduced its Eli Lilly (LLY) stake by 5.8% in Q3 2026, selling an estimated $29.5K and leaving 406 shares worth $470K. The position accounts for 0.21% of the portfolio, ranked #39.

Broadway Wealth Solutions first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $517K in Q2 2026. 2,398 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Broadway Wealth Solutions held 406 shares of Eli Lilly worth $470K as of Q3 2026.
  • Broadway Wealth Solutions sold 25 Eli Lilly shares in Q3 2026, an estimated $29.5K.
  • Eli Lilly made up 0.21% of Broadway Wealth Solutions's portfolio in Q3 2026, its #39 holding.
  • Broadway Wealth Solutions first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Broadway Wealth Solutions's Eli Lilly position peaked at $517K in Q2 2026.
  • 2,398 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Broadway Wealth Solutions's 13F filing for Q3 2026, filed 21 Oct 2026.